LMG Wealth Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
LMG Wealth Partners's PFE Position: Q1 2026 in Review
LMG Wealth Partners reduced its Pfizer (PFE) stake by 2.1% in Q1 2026, selling an estimated $9.8K and leaving 17,567 shares worth $493K. The position accounts for 0.09% of the portfolio, ranked #115.
LMG Wealth Partners first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.37M in Q4 2022. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- LMG Wealth Partners held 17,567 shares of Pfizer worth $493K as of Q1 2026.
- LMG Wealth Partners sold 368 Pfizer shares in Q1 2026, an estimated $9.8K.
- Pfizer made up 0.09% of LMG Wealth Partners's portfolio in Q1 2026, its #115 holding.
- LMG Wealth Partners first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
- LMG Wealth Partners's Pfizer position peaked at $1.37M in Q4 2022.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on LMG Wealth Partners's 13F filing for Q1 2026, filed 17 Apr 2026.